SRA's number for the day: 92
This article was originally published in SRA
In its first year of operation, the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee looked at a total of 92 safety signals relating to drugs marketed in the EU.
You may also be interested in...
Sanofi failed in its attempt to have its EU marketing authorization application for avalglucosidase alfa fast-tracked through the centralized review process at the European Medicines Agency. This and other developments relating to the agency's accelerated assessment mechanism are logged in this latest update to the Pink Sheet's EU accelerated assessment tracker.
Change in leadership at the European Medicines Agency comes at a critical time.
The change in leadership at the European Medicines Agency comes at a critical time.